For the nine month period ended September 30, 2007, net loss was $9.8 million, or $0.25 per diluted share, compared to a net loss of $10.9 million, or $0.29 per diluted share, in the same period in 2006.
As of September 30, 2007, cash balances equivalents were $99.6 million, compared to $19.8 million at December 31, 2006. The increase in cash balance is attributable to the net proceeds of $61.1 million that the Company received following the listing of its subsidiary on the AIM market.
About MGT Capital Investments, Inc.
MGT Capital Investments, Inc is a holding company that focuses on investments in the global healthcare information technology market. The Company has two subsidiaries, Medicsight PLC and Medicexchange PLC.
Medicsight PLC (traded on the AIM market of the London Stock Exchange, under the Ticker symbol MDST) is a medical imaging software development company developing enterprise-wide Computer-Aided Detection (CAD) software which analyzes computer tomography (CT) scans for the early detection and measurement of colorectal polyps and lung lesions. Medicsight has focused on two of the leading causes of cancer-related death, colorectal cancer and lung cancer.
Medicexchange PLC provides medical imaging professionals with a global web portal containing an online sales, jobs and information channel for diagnostic, treatment and surgery planning solutions. This combined with a variety of relevant clinical papers, training materials and content gives these professionals access to information and products that they otherwise would have difficulty accessing.
Additional information can be found at http://www.mgtci.com.
All forward-looking statements are made pursuant to the 'safe harbor'
'/>"/>
| SOURCE MGT Capital Investments, Inc. Copyright©2007 PR Newswire. All rights reserved |